MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study.

Ehdaie B, Tempany CM, Holland F, Sjoberg DD, Kibel AS, Trinh QD, Durack JC, Akin O, Vickers AJ, Scardino PT, Sperling D, Wong JYC, Yuh B, Woodrum DA, Mynderse LA, Raman SS, Pantuck AJ, Schiffman MH, McClure TD, Sonn GA, Ghanouni P

Open source

DOI: 10.1016/s1470-2045(22)00251-0
Published: 2022 Jul
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-22-00251-0,
  title = {MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study.},
  author = {Ehdaie B and Tempany CM and Holland F and Sjoberg DD and Kibel AS and Trinh QD and Durack JC and Akin O and Vickers AJ and Scardino PT and Sperling D and Wong JYC and Yuh B and Woodrum DA and Mynderse LA and Raman SS and Pantuck AJ and Schiffman MH and McClure TD and Sonn GA and Ghanouni P},
  year = {2022},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(22)00251-0},
  url = {https://doi.org/10.1016/s1470-2045(22)00251-0}
}

RIS

TY  - JOUR
TI  - MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study.
AU  - Ehdaie B
AU  - Tempany CM
AU  - Holland F
AU  - Sjoberg DD
AU  - Kibel AS
AU  - Trinh QD
AU  - Durack JC
AU  - Akin O
AU  - Vickers AJ
AU  - Scardino PT
AU  - Sperling D
AU  - Wong JYC
AU  - Yuh B
AU  - Woodrum DA
AU  - Mynderse LA
AU  - Raman SS
AU  - Pantuck AJ
AU  - Schiffman MH
AU  - McClure TD
AU  - Sonn GA
AU  - Ghanouni P
PY  - 2022
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(22)00251-0
UR  - https://doi.org/10.1016/s1470-2045(22)00251-0
ER  -

APA

B, E., CM, T., F, H., DD, S., AS, K., QD, T., JC, D., O, A., AJ, V., PT, S., D, S., JYC, W., B, Y., DA, W., LA, M., SS, R., AJ, P., MH, S., TD, M., GA, S., & P, G. (2022). MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(22)00251-0

Source records

pubmed · retrieved 2026-09-26T20:24:16.118Z